Skip to main content
FOCIS 2023 Main banner
Final Program


Scientific Program
Back
ViewAttendees 2

ImmunoOncology and Cell Therapy

Wednesday, June 21, 2023
3:15 PM – 5:30 PM  
Location: Salon A-D

Sponsored By 

Presentations:

  • 3:15 PM – 3:30 PM  
    CART-cell Therapy Directed Towards Novel CD84 Antigen for the Treatment of Acute Myeloid Leukemia

    Presenting Author: Manel Juan, MD, PhD – Hospital Clinic de Barcelona

  • 3:30 PM – 3:45 PM  
    Removal of Endogenous TCR Chains for Tcr-based Immunotherapies

    Presenting Author: Giorgia Zanetti – Columbia University

  • 3:45 PM – 4:00 PM  
    Unique Cellular and Autoantibody Signatures in Patients with Iraes Revealed by Longitudinal Immune Tracking

    Presenting Author: Sokratis Apostolidis, MD – University of Pennsylvania

  • 4:00 PM – 4:15 PM  
    CRISPR/Cas9-Based Editing of KLRC1 Enhances the Efficacy of Primary CD33-Targeting CAR-NK Cells Against Acute Myeloid Leukemia

    Presenting Author: Evelyn Ullrich, MD – Goethe University Frankfurt

  • 4:15 PM – 4:30 PM  
    FOXp3+ Regulatory T Cells Co-localize with CD8+ T Cells in Tumors Responding to PD-1 Blockade

    Presenting Author: Mikhael Attias – McGill University

  • 4:30 PM – 4:45 PM  
    Local and Systemic Immune Response Against Tumor Specific and Tumor-associated Antigens in Patients with Localized Uveal Melanoma (UM)

    Presenting Author: Ana I. Lalanne, Ph.D. – Institut Curie

  • 4:45 PM – 5:00 PM  
    Immuno-stat Platform: Tcr-selective Engagers for Selective Targeting of IL-2 to Tumor-specific T Cells

    Presenting Author: Steven Quayle, Ph.D. – Cue Biopharma

  • 5:00 PM – 5:15 PM  
    Selective Depletion of Follicular Helper T Cells Using Chimeric Antigen Receptor Natural Killer Cells

    Presenting Author: Nora Lakes – Cincinnati Children's Hospital Medical Center

  • 5:15 PM – 5:30 PM  
    Antibodies to PODXL as an Approach to Targeting Tumor Stem Cells

    Presenting Author: Kelly M. McNagny, PhD – University of British Columbia